Today: 1 May 2026
Browse Category

NYSE:JNJ 16 January 2026 - 24 January 2026

Gilead stock jumps again as Trodelvy-Keytruda breast cancer data hit NEJM

Gilead stock jumps again as Trodelvy-Keytruda breast cancer data hit NEJM

Gilead Sciences shares rose 3.5% to $135.73 Friday, hitting new highs after Phase 3 trial data showed its Trodelvy-Keytruda combo cut the risk of disease progression or death by 35% in metastatic triple-negative breast cancer. Gilead has filed for expanded approval in the U.S. and Europe. Volume reached 8.8 million shares. A Form 144 filing showed executive Deborah Telman plans to sell up to 29,215 shares.
23 January 2026
·····
Johnson & Johnson stock today: Why JNJ can’t break out as talc risk shadows upbeat 2026 outlook

Johnson & Johnson stock today: Why JNJ can’t break out as talc risk shadows upbeat 2026 outlook

Johnson & Johnson shares traded nearly flat at $218.59 by late Friday morning as Wall Street upgrades met renewed worries over federal talc lawsuits. A special master recommended allowing plaintiffs’ experts to testify that J&J talc products can cause ovarian cancer, affecting over 67,500 cases. The company reported Q4 sales up 9.1% to $24.6 billion and projected 2026 sales of up to $101 billion.
23 January 2026
··
Johnson & Johnson stock price today: JNJ ends higher, but talc case stays in focus after earnings

Johnson & Johnson stock price today: JNJ ends higher, but talc case stays in focus after earnings

Johnson & Johnson closed up 0.3% at $218.49 Thursday after reporting Q4 revenue of $24.56 billion and adjusted earnings of $2.46 per share. The company projected 2026 sales above estimates but faces ongoing pressure from U.S. drug pricing, tariffs, and talc litigation. A court-appointed special master recommended allowing expert testimony in the New Jersey talc case. J&J plans to appeal.
22 January 2026
···
Johnson & Johnson stock price rises today as investors weigh 2026 outlook — and talc lawsuit clock

Johnson & Johnson stock price rises today as investors weigh 2026 outlook — and talc lawsuit clock

Johnson & Johnson shares rose 1.1% to $220.36 Thursday after the company posted fourth-quarter sales of $24.564 billion and adjusted EPS of $2.46, beating forecasts. J&J projected 2026 adjusted EPS of $11.43–$11.63 and sales up to $101 billion. The company warned of a $500 million tariff hit and ongoing legal risks from talc lawsuits. Investors reacted to declining Stelara sales and competition in medical devices.
22 January 2026
·
Johnson & Johnson stock price swings late as JNJ guidance beats views, but talc risk grabs traders again

Johnson & Johnson stock price swings late as JNJ guidance beats views, but talc risk grabs traders again

Johnson & Johnson shares slipped 0.05% to $218.01 in after-hours trading Wednesday after the company projected 2026 sales and profits above Wall Street estimates. Investors weighed the upbeat forecast against renewed legal risks as a court-appointed special master recommended allowing expert testimony in federal talc litigation involving over 67,500 lawsuits. J&J plans to appeal the ruling.
22 January 2026
···
Why Johnson & Johnson stock is slipping today after JNJ’s 2026 forecast

Why Johnson & Johnson stock is slipping today after JNJ’s 2026 forecast

Johnson & Johnson shares fell 1.3% to $215.31 after its 2026 outlook and Q4 results, as renewed legal risks and pricing pressures weighed on investors. The company reported Q4 sales of $24.564 billion and forecasted 2026 adjusted EPS of $11.43–$11.63. Legal pressure increased after a special master advised allowing expert testimony in talc cancer lawsuits. Tariff risks and Stelara's decline added to market concerns.
21 January 2026
·
Johnson & Johnson stock price slips after-hours ahead of earnings as tariff fears rattle markets

Johnson & Johnson stock price slips after-hours ahead of earnings as tariff fears rattle markets

Johnson & Johnson shares slipped 0.2% to $218.21 in after-hours trading Tuesday ahead of quarterly earnings due Wednesday. The move followed a broad market selloff, with the Dow down 1.76% and the S&P 500 off 2.06% after new U.S. tariff threats. Analysts expect Q4 profit of $2.47 per share. The company faces ongoing litigation, including a $1.5 billion verdict over talc products.
21 January 2026
··
Dow Jones futures drop on Trump tariff threat as Wall Street sets up for Netflix, PCE week

Dow Jones futures drop on Trump tariff threat as Wall Street sets up for Netflix, PCE week

The Dow closed down 0.2% at 49,359.33 on Friday ahead of the MLK Day market holiday. Dow futures fell 0.7% after President Trump threatened a 10% tariff on imports from eight European nations tied to Greenland, with the rate set to rise to 25% in June if talks fail. European leaders condemned the move and gold hit new highs as investors sought safety. Traders await key earnings and Thursday’s PCE inflation data.
19 January 2026
·····
Trump’s Greenland tariff threat sets up a tense week for global stocks

Trump’s Greenland tariff threat sets up a tense week for global stocks

President Donald Trump threatened 10% tariffs on eight European countries tied to Greenland, escalating to 25% by June if no deal is reached. The S&P 500 closed nearly flat at 6,940.01, while the Dow and Nasdaq also posted slight losses. Europe’s STOXX 600 ended flat, and China’s regulator announced tighter market controls. U.S. markets will close Monday for Martin Luther King Jr. Day.
18 January 2026
···
Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

Johnson & Johnson shares closed down 0.4% at $218.66 Friday ahead of the Martin Luther King Jr. Day market holiday. The S&P 500 health care sector fell 0.8%. J&J reports fourth-quarter results Wednesday, Jan. 21, with investors focused on earnings and 2026 guidance. The NYSE will reopen Tuesday after the holiday.
18 January 2026
·······
Supreme Court Fed showdown, Davos and China GDP: what to watch in global markets next week

Supreme Court Fed showdown, Davos and China GDP: what to watch in global markets next week

The U.S. Supreme Court will hear arguments Wednesday on President Trump’s effort to remove Fed Governor Lisa Cook. Stocks ended the week lower, with the S&P 500 at 6,940.01 and Brent crude at $64.13. China releases GDP data as Davos opens, while Japan nears a possible snap election. Prime Minister Takaichi may suspend Japan’s 8% food sales tax, risking a 5 trillion yen revenue hit.
18 January 2026
····
Johnson & Johnson stock slips — what traders watch before JNJ earnings

Johnson & Johnson stock slips — what traders watch before JNJ earnings

Johnson & Johnson shares closed down 0.41% at $218.66 Friday and were flat after hours. The company reports fourth-quarter earnings January 21, with investors watching for updates on drug approvals and MedTech growth. FDA fast-track reviews and consumer-health deals remain in focus. Kenvue, spun off from J&J, faces a key shareholder vote January 29 on its sale to Kimberly-Clark.
17 January 2026
··
1 2 3 4 5 … 8

Stock Market Today

  • Teladoc Q1 CY2026 Revenue Beats Estimates but Shares Decline
    April 30, 2026, 11:39 PM EDT. Teladoc Health (NYSE:TDOC) reported Q1 CY2026 revenue of $613.8 million, slightly surpassing analyst forecasts by 0.5% despite a 2.5% year-on-year decline. The company's GAAP loss per share was $0.36, missing estimates by 4.7%. Adjusted EBITDA of $58.17 million exceeded expectations. Full-year revenue guidance of $2.53 billion beat consensus, but next quarter's sales guidance at $611.5 million fell 2% short. Teladoc's operating margin improved to -10.1% from -19.2% a year ago, yet free cash flow turned negative at -$24.65 million, down from a positive $85.12 million previously. The telemedicine platform continues to face stagnant revenue growth, with analysts predicting flat sales over the coming year despite new product launches. Market capitalization stands at $1.08 billion.

Latest article

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

30 April 2026
Nvidia shares dropped 4.6% to $199.57 Thursday as investors reacted to Alphabet and Amazon expanding sales of their own AI chips. Alphabet reported Google Cloud revenue up 63% and began selling TPU chips directly to customers. AMD and Broadcom shares rose 5.1% and 3.0%, respectively. Amazon said its Trainium chip line secured $225 billion in revenue commitments.
Go toTop